ConductScience.org, home

Paper776441

Patient acceptance of guanethidine as therapy for mild to moderate hypertension. A comparison with reserpine.

Ferguson RK and 2 others. Circulation, 1976. Cited by 28 papers, by iCite.

Cite this record

ConductScience Library. Patient acceptance of guanethidine as therapy for mild to moderate hypertension. A comparison with reserpine. Papers, record 776441. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/776441

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Patient acceptance of guanethidine as therapy for mild to moderate hypertension. A comparison with reserpine.
PubMed
Journal
Circulation
PubMed
Year
1976
PubMed
Publication types
Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
28
iCite
Relative citation ratio, by iCite
1.62
iCite
Revised in PubMed
2019-06-23
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ferguson RKR K
2Rothenberg RJR J
3Nies ASA S

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
GuanethidineMajor topic
HypertensionMajor topic
ReserpineMajor topic
Body Weight
Clinical Trials as Topic
Drug Resistance
Evaluation Studies as Topic
Female
Heart Rate
Humans
Hydrochlorothiazide
Male
Patient Compliance

Source PubMed

Download CSV of topics

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 28 citations.

PMIDTitleJournalYearIn PapersSource
27997978Blood pressure-lowering efficacy of reserpine for primary hypertension.Cochrane Database Syst Rev2016https://conductscience.org/library/papers/27997978PubMed
6517689Preliminary observations of the utility of portable NPT.Arch Sex Behav1984https://conductscience.org/library/papers/6517689PubMed
3054427Drug-induced sexual dysfunction.Med Toxicol Adverse Drug Exp1988https://conductscience.org/library/papers/3054427PubMed
1810301Reserpine: a relic from the past or a neglected drug of the present for achieving cost containment in treating hypertension?J Gen Intern Med1991https://conductscience.org/library/papers/1810301PubMed
490669Treating hypertension among inner-city dwellers: the problem of noncompliance.J Natl Med Assoc1979https://conductscience.org/library/papers/490669PubMed
23938Drug interactions with antihypertensive drugs.Drugs1978https://conductscience.org/library/papers/23938PubMed
23284Antihypertensive drugs: clinical pharmacology and therapeutic use.Drugs1977https://conductscience.org/library/papers/23284PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/776441

GET https://conductscience.org/api/papers/v1/776441/authors